Former Pittsburgh Steel Mill to Become Biomedical-Manufacturing Plant With Mellon Grant

SourceWall Street Journal
Date Published11/17/2021
Author NameKris Maher
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Pitt BioForge
Parent companyPitt BioForge
Type of work Manufacturing
Reshoring category:Reshoring
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2022
Capital investment ($):100
City reshored to:Pittsburgh
State(s) reshored to:PA
If relevant, work nearshored to:-
Product(s) reshoredgene therapy
What domestic positive factors made reshoring more attractive?Government Incentives, Infrastructure, Image/brand, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training, Under-utilized capacity
Find Reshoring Articles